Both in Surgical Instruments
DexCom vs ResMed
Over the past year DXCM returned +30.4% and RMD returned −17.8%; their daily moves had a correlation of 0.34.
DXCM +30.4% RMD −17.8%Growth of $1, one year, split-adjusted
| Metric | DXCM | RMD |
|---|---|---|
| Price | $86.64 | $222.83 |
| Market cap | $32.69B | $32.14B |
| Today | −0.05% | +0.33% |
| 1 month | −4.6% | −7.3% |
| 6 months | +40.0% | +1.3% |
| Year to date | +30.5% | −7.5% |
| 1 year | +29.1% | −17.6% |
| Revenue growth (YoY) | +13.1% | +8.6% |
| Gross margin | 63.4% | 59.4% |
| Net margin | 19.0% | 26.2% |
| P/E (TTM) | 32.7× | 21.1× |
| Price / sales | 6.6× | 5.7× |
| Net cash | $704.2M | $809.9M |
| Dividend yield | — | 1.18% |
| Volatility (60d) | 39.6% | 33.6% |
| Short % of float | 4.6% | 9.9% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).